TAVR for severe aortic valve regurgitation
Part of Heart & circulation clinical trials.
This trial tests a procedure called TAVR to replace the aortic valve in people with severe aortic regurgitation (a leaky valve). It may help you if you have this condition and prefer a less invasive option than open-heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aortic valve regurgitation (a leaky valve that lets blood flow backward).
- A team of heart specialists has said that TAVR (a valve replacement through a tube in your artery) is a good option for you.
- You understand the study and are willing to sign a consent form.
- You are not getting TAVR for aortic stenosis (a tight valve, not a leaky one).
- You are not taking part in any other clinical trial right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people who have severe aortic valve regurgitation and get a TAVR. It looks at how well the valve works over time and how patients do in the long run.
This trial is studying how well a new type of heart valve works in real-life patients with aortic valve disease. It will help doctors understand if this valve is safe and effective for people who need a procedure called TAVR (transcatheter aortic valve replacement).
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
This study uses a catheter-based procedure to replace a severely leaking aortic valve without open-heart surgery. It may help people who have symptoms or heart damage from a leaky valve and are not good candidates for surgery.
Hear when a new Aortic Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.